Database analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.

ABSTRACT:

Background

Eleven previous reports have shown potential benefit of a 36-ingredient micronutrient formula (known as EMPowerplus) for the treatment of psychiatric symptoms. The current study asked whether children (7-18 years) with pediatric bipolar disorder (PBD) benefited from this same micronutrient formula; the impact of Attention-Deficit/Hyperactivity Disorder (ADHD) on their response was also evaluated.

Methods

Data were available from an existing database for 120 children whose parents reported a diagnosis of PBD; 79% were taking psychiatric medications that are used to treat mood disorders; 24% were also reported as ADHD. Using Last Observation Carried Forward (LOCF), data were analyzed from 3 to 6 months of micronutrient use.

Results

At LOCF, mean symptom sever

SUBMITTER: Rucklidge JJ 

PROVIDER: S-EPMC2954995 | biostudies-literature | 2010 Sep

REPOSITORIES: biostudies-literature